Fox Run Management, L.L.C. Tandem Diabetes Care Inc Transaction History

Fox Run Management, L.L.C.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$24.18 - $42.46 $265,085 - $465,488	10,963 New	10,963 $269,000
Q2 2022 Aug 12, 2022	BUY	$53.22 - $123.09 $220,916 - $510,946	4,151 New	4,151 $246,000
Q3 2021 Nov 15, 2021	SELL	$93.51 - $129.4 $364,782 - $504,789	-3,901 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$77.0 - $100.19 $300,377 - $390,841	3,901 New	3,901 $380,000
Q2 2019 Jul 17, 2019	SELL	$54.41 - $71.7 $510,202 - $672,330	-9,377 Closed	0 $0
Q1 2019 Oct 17, 2019	BUY	$32.25 - $73.56 $302,408 - $689,772	9,377 New	9,377 $595,000
Q4 2018 Jan 15, 2019	SELL	$28.45 - $40.65 $134,568 - $192,274	-4,730 Closed	0 $0
Q3 2018 Oct 05, 2018	BUY	$21.39 - $51.17 $101,174 - $242,034	4,730 New	4,730 $203,000

359

72.2M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $2.37B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.